EUVIMEDEUVIMED entdecken
Open Access

TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma

Ya-Qin Wang iD, Dong-Hong Wu iD, Denghui Wei iD, Jia-Yi Shen iD, Zi-Wei Huang iD, Xiao-Yu Liang, William C S Cho iD, Jun Ma iD, Jiawei Lv iD, Yu-Pei Chen iD

Science Advances · 2023

DOI: 10.1126/sciadv.add0960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Ya-Qin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carci…. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The molecular basis underlying nasopharyngeal carcinoma (NPC) remains unclear. Recent progress in transcriptional regulatory network analysis helps identify the master regulator (MR) proteins that transcriptionally define malignant tumor phenotypes. Here, we investigated transcription factor-target interactions and identified TEA domain transcription factor 4 (TEAD4) as an MR of high-risk NPC. Precisely, TEAD4 promoted NPC migration, invasion and cisplatin resistance, depending on its autopalmitoylation. Mechanistically, YTHDF2 (YTH domain family 2) recognized WTAP (Wilms tumor 1–associating protein)–mediated TEAD4 m 6 A methylation to facilitate its stability and led to aberrant up-regulation of TEAD4. Up-regulated TEAD4 further drove NPC progression by transcriptionally activating BZW2 (basic leucine zipper and W2 domains 2) to induce the oncogenic AKT pathway. Moreover, the transcriptional activity of TEAD4 was independent of its canonical coactivators YAP/TAZ. Clinically, TEAD4 serves as an independent predictor of unfavorable prognosis and cisplatin response in NPC. Our data revealed the crucial role of TEAD4 in driving tumor malignancy, thus, may provide therapeutic vulnerability in NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsNasopharyngeal NeoplasmsHumansCell Line, TumorCell ProliferationCisplatinGene Expression Regulation, NeoplasticNasopharyngeal CarcinomaTEA Domain Transcription FactorsTranscription FactorsSS-A Antigen5'-NucleotidaseGPI-Linked Proteins

Substanzen

CisplatinDNA-Binding ProteinsTEA Domain Transcription FactorsTranscription FactorsSS-A AntigenBZW2 protein, humanTEAD4 protein, humanNT5E protein, human5'-NucleotidaseGPI-Linked Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-s…
  • Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510060, P.R. China.
  • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, Hong Kong, P.R. China.

ORCID-Profile: Ya-Qin Wang, Dong-Hong Wu, Denghui Wei, Jia-Yi Shen, Zi-Wei Huang, William C S Cho, Jun Ma, Jiawei Lv, Yu-Pei Chen

Zitieren

APA

Wang, Y. Q., Wu, D. H., Wei, D., Shen, J. Y., Huang, Z. W., Liang, X. Y., Cho, W. C. S., Ma, J., Lv, J., & Chen, Y. P. (2023). TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma. Science Advances. https://doi.org/10.1126/sciadv.add0960

Vancouver

Wang YQ, Wu DH, Wei D, Shen JY, Huang ZW, Liang XY, et al. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma. Science Advances. 2023. doi:10.1126/sciadv.add0960

BibTeX
@article{Wang2023,
  author = {Wang, Ya-Qin and Wu, Dong-Hong and Wei, Denghui and Shen, Jia-Yi and Huang, Zi-Wei and Liang, Xiao-Yu and Cho, William C S and Ma, Jun and Lv, Jiawei and Chen, Yu-Pei},
  title = {TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.add0960}
}
Kostenlos starten →